Jason Kantor

  • Biotech/Health Care

    By Janet Levaux, AdvisorOne  |  September 1, 2008

    Thanks to new drugs, acquisitions and other factors, biotech and health-care firms alike are forging beneficial growth and development strategies - which is good news...

  • Healthy Entrance

    By Janet Levaux, AdvisorOne  |  March 1, 2008

    Stocks in health care, including biotech and pharmaceuticals, are poised for higher levels in 2008 - thanks to present valuations, developing pipelines and acquisition horizons,...

  • A Time of Innovation

    By Staff Writer  |  September 1, 2006

    New products and other factors drive growth in health care/biotech, despite a cautious regulatory environment, analysts say. ----- Jason Kantor RBC Capital Markets 415-633-8565 Jason.kantor@rbccm.com Outlook: Fundamentally, I don't think the...